• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A theory on SARS-COV-2 susceptibility: reduced TLR7-activity as a mechanistic link between men, obese and elderly.

作者信息

Englmeier L

机构信息

Patent Attorney Dr. Ludwig Englmeier, Erlenaustrasse 11, 83080 Oberaudorf, Germany. e-mail:

出版信息

J Biol Regul Homeost Agents. 2020 May-Jun;34(3):1125-1129. doi: 10.23812/20-221-L-49.

DOI:10.23812/20-221-L-49
PMID:32456409
Abstract
摘要

相似文献

1
A theory on SARS-COV-2 susceptibility: reduced TLR7-activity as a mechanistic link between men, obese and elderly.一种关于新冠病毒易感性的理论：TLR7活性降低作为男性、肥胖者和老年人之间的机制联系。
J Biol Regul Homeost Agents. 2020 May-Jun;34(3):1125-1129. doi: 10.23812/20-221-L-49.
2
Why Females Do Better: The X Chromosomal TLR7 Gene-Dose Effect in COVID-19.为何女性表现更佳：COVID-19 中 X 染色体 TLR7 基因剂量效应。
Front Immunol. 2021 Nov 11;12:756262. doi: 10.3389/fimmu.2021.756262. eCollection 2021.
3
Genetic Screening for Variants in Young and Previously Healthy Men With Severe COVID-19.对患有严重 COVID-19 的年轻且既往健康男性的变异进行遗传筛查。
Front Immunol. 2021 Jul 23;12:719115. doi: 10.3389/fimmu.2021.719115. eCollection 2021.
4
Female predisposition to TLR7-driven autoimmunity: gene dosage and the escape from X chromosome inactivation.女性易患 TLR7 驱动的自身免疫病：基因剂量和 X 染色体失活逃逸。
Semin Immunopathol. 2019 Mar;41(2):153-164. doi: 10.1007/s00281-018-0712-y. Epub 2018 Oct 1.
5
Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control study.TLR7 变异与男性 COVID-19 重症患者的相关性：巢式病例对照研究的结果。
Elife. 2021 Mar 2;10:e67569. doi: 10.7554/eLife.67569.
6
X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19.约 1%的 60 岁以下患有危及生命的 COVID-19 的男性存在 X 连锁隐性 TLR7 缺陷。
Sci Immunol. 2021 Aug 19;6(62). doi: 10.1126/sciimmunol.abl4348.
7
What's happening where when SARS-CoV-2 infects: are TLR7 and MAFB sufficient to explain patient vulnerability?当新型冠状病毒感染时，体内发生了什么：Toll样受体7（TLR7）和MAFB足以解释患者的易感性吗？
Immun Ageing. 2022 Jan 22;19(1):6. doi: 10.1186/s12979-022-00262-3.
8
The role of TLR7 agonists in modulating COVID-19 severity in subjects with loss-of-function TLR7 variants.TLR7 激动剂在功能丧失型 TLR7 变异体患者中调节 COVID-19 严重程度中的作用。
Sci Rep. 2023 Aug 11;13(1):13078. doi: 10.1038/s41598-023-40114-8.
9
High Expression Drives the Expansion of CD19CD24CD38 Transitional B Cells and Autoantibody Production in SLE Patients.高表达驱动 SLE 患者 CD19CD24CD38 过渡性 B 细胞的扩增和自身抗体产生。
Front Immunol. 2019 Jun 4;10:1243. doi: 10.3389/fimmu.2019.01243. eCollection 2019.
10
The association of single nucleotide polymorphisms of Toll-like receptor 3, Toll-like receptor 7 and Toll-like receptor 8 genes with the susceptibility to HCV infection.Toll样受体3、Toll样受体7和Toll样受体8基因单核苷酸多态性与丙型肝炎病毒感染易感性的关联。
Br J Biomed Sci. 2018 Oct;75(4):175-181. doi: 10.1080/09674845.2018.1492186. Epub 2018 Aug 23.

引用本文的文献

1
A comprehensive review on pharmacologic agents, immunotherapies and supportive therapeutics for COVID-19.关于COVID-19的药物制剂、免疫疗法和支持性疗法的全面综述。
Narra J. 2022 Dec;2(3):e92. doi: 10.52225/narra.v2i3.92. Epub 2022 Dec 8.
2
Study on Potential Differentially Expressed Genes in Idiopathic Pulmonary Fibrosis by Bioinformatics and Next-Generation Sequencing Data Analysis.基于生物信息学和二代测序数据分析的特发性肺纤维化潜在差异表达基因研究
Biomedicines. 2023 Nov 21;11(12):3109. doi: 10.3390/biomedicines11123109.
3
Immune Factors Drive Expression of SARS-CoV-2 Receptor Genes Amid Sexual Disparity.
免疫因子在性别差异中驱动 SARS-CoV-2 受体基因的表达。
Viruses. 2023 Feb 28;15(3):657. doi: 10.3390/v15030657.
4
What's happening where when SARS-CoV-2 infects: are TLR7 and MAFB sufficient to explain patient vulnerability?当新型冠状病毒感染时，体内发生了什么：Toll样受体7（TLR7）和MAFB足以解释患者的易感性吗？
Immun Ageing. 2022 Jan 22;19(1):6. doi: 10.1186/s12979-022-00262-3.
5
In silico Design and Characterization of Multi-epitopes Vaccine for SARS-CoV2 from Its Spike Protein.基于新冠病毒刺突蛋白的多表位疫苗的计算机设计与表征
Int J Pept Res Ther. 2022;28(1):37. doi: 10.1007/s10989-021-10348-z. Epub 2022 Jan 3.
6
An Overview of Recent Insights into the Response of TLR to SARS-CoV-2 Infection and the Potential of TLR Agonists as SARS-CoV-2 Vaccine Adjuvants.TLR 对 SARS-CoV-2 感染反应的最新研究进展概述及 TLR 激动剂作为 SARS-CoV-2 疫苗佐剂的潜力。
Viruses. 2021 Nov 18;13(11):2302. doi: 10.3390/v13112302.
7
Innate and Adaptive Immunity Alterations in Metabolic Associated Fatty Liver Disease and Its Implication in COVID-19 Severity.代谢相关脂肪性肝病中先天性和适应性免疫的改变及其对COVID-19严重程度的影响。
Front Immunol. 2021 Mar 30;12:651728. doi: 10.3389/fimmu.2021.651728. eCollection 2021.
8
Epidemiology of COVID-19 in Mexico: Symptomatic profiles and presymptomatic people.墨西哥 COVID-19 流行病学：症状特征和症状前人群。
Int J Infect Dis. 2021 Mar;104:572-579. doi: 10.1016/j.ijid.2020.12.086. Epub 2021 Jan 9.
9
Early Humoral Response Correlates with Disease Severity and Outcomes in COVID-19 Patients.早期体液免疫反应与 COVID-19 患者的疾病严重程度和结局相关。
Viruses. 2020 Dec 4;12(12):1390. doi: 10.3390/v12121390.
10
Candesartan could ameliorate the COVID-19 cytokine storm.坎地沙坦可改善 COVID-19 细胞因子风暴。
Biomed Pharmacother. 2020 Nov;131:110653. doi: 10.1016/j.biopha.2020.110653. Epub 2020 Aug 20.